These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 10794811)
1. Cisplatin plus vinorelbine for patients with advanced head and neck squamous cell carcinoma. Segura A; Pastor M; Santaballa A; Yuste A; López P; Aparicio J Oncologist; 2000; 5(2):177-8. PubMed ID: 10794811 [No Abstract] [Full Text] [Related]
2. Vinorelbine plus cisplatin in recurrent or previously untreated unresectable squamous cell carcinoma of the head and neck. Gebbia V; Testa A; Di Gregorio C; Ingria F; Valenza R; Cannata G; Moschella F; Restivo G; Gebbia N Am J Clin Oncol; 1995 Aug; 18(4):293-6. PubMed ID: 7625368 [TBL] [Abstract][Full Text] [Related]
3. Acute tumor pain in patients with head and neck cancer treated with vinorelbine. Kornek GV; Kornfehl H; Hejna M; Raderer M; Zöchbauer S; Scheithauer W J Natl Cancer Inst; 1996 Nov; 88(21):1593. PubMed ID: 8901858 [No Abstract] [Full Text] [Related]
4. Comparative study of efficacy and toxicities of cisplatin vs vinorelbine as radiosensitisers in locally advanced head and neck cancer. Sarkar SK; Patra NB; Goswami J; Basu S J Laryngol Otol; 2008 Feb; 122(2):188-92. PubMed ID: 17445333 [TBL] [Abstract][Full Text] [Related]
5. Randomized phase II study of cisplatin and 5-FU continuous infusion (PF) versus cisplatin, UFT and vinorelbine (UFTVP) as induction chemotherapy in locally advanced squamous cell head and neck cancer (LA-SCHNC). Rivera F; Vega-Villegas ME; López-Brea M; Isla D; Mayorga M; Galdós P; Rubio A; Del Valle A; García-Reija F; García-Montesinos B; Rodríguez-Iglesias J; Mayordomo J; Rama J; Saiz-Bustillo R; Sanz-Ortiz J Cancer Chemother Pharmacol; 2008 Jul; 62(2):253-61. PubMed ID: 17901953 [TBL] [Abstract][Full Text] [Related]
6. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck. Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121 [TBL] [Abstract][Full Text] [Related]
7. Chemotherapy in advanced squamous cell carcinoma of the head and neck with methotrexate, bleomycin and cisplatin. Hupperets PS; Van der Vegt SG; Bruaset I; Van den Broek P; Wagener DJ Neth J Med; 1985; 28(9):352-5. PubMed ID: 2413380 [No Abstract] [Full Text] [Related]
8. Neo-adjuvant chemotherapy +/- immunotherapy with s.c. IL 2 in advanced squamous cell carcinoma of the head and neck: a pilot study. Mantovani G; Bianchi A; Curreli L; Ghiani M; Santona MC; Proto E; Puxeddu P Biotherapy; 1994; 8(2):91-8. PubMed ID: 8924357 [TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant carboplatin and vinorelbine followed by chemoradiotherapy in locally advanced head and neck or oesophageal squamous cell carcinoma: a phase II study in elderly patients or patients with poor performance status. Koussis H; Scola A; Bergamo F; Tonello S; Basso U; Karahontzitis P; Chiarion-Sileni V; Pasetto L; Ruol A; Loreggian L; Lora O; Bottin R; Marioni G; Donach M; Jirillo A Anticancer Res; 2008; 28(2B):1383-8. PubMed ID: 18505084 [TBL] [Abstract][Full Text] [Related]
10. Vinorelbine and cisplatin in advanced squamous cell carcinoma of the cervix: the South African experience. Goedhals L; Falkson G; Smith BL; Falkson CI; Gasmi J; Lategan A; Burillon JP; His P Anticancer Res; 2005; 25(3c):2489-92. PubMed ID: 16080481 [TBL] [Abstract][Full Text] [Related]
11. A phase II trial of cisplatin and vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. Espinosa E; Zamora P; Millá A; Morales S; Molina R; Mira M; González Barón M; Head Neck; 2002 Dec; 24(12):1054-9. PubMed ID: 12454943 [TBL] [Abstract][Full Text] [Related]
12. Phase II trial of vinorelbine, cisplatin and continuous infusion of 5-fluorouracil followed by hyperfractionated radiotherapy in locally advanced head and neck cancer. Orecchia R; Jereczek-Fossa BA; Catalano G; Chiesa F; De Pas T; Masci G; Krengli M; Vavassori A; De Paoli F; Robertson C; Marrocco E; De Braud F Oncology; 2002; 63(2):115-23. PubMed ID: 12239445 [TBL] [Abstract][Full Text] [Related]
13. Phase II study of vinorelbine/cetuximab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck progressing after at least two chemotherapy regimens. Massa E; Dessì M; Gaspardini G; Saba F; Cherchi V; Mantovani G Oral Oncol; 2010 Nov; 46(11):818-21. PubMed ID: 20920877 [TBL] [Abstract][Full Text] [Related]
14. A pilot study of cisplatin-vinblastine as the initial treatment of advanced head and neck cancer. Leitner SP; Bosl GJ; Strong EW; Gerold FP; Spiro RH; Shah JP; Sessions RB; Vikram B Cancer; 1986 Sep; 58(5):1014-7. PubMed ID: 3731034 [TBL] [Abstract][Full Text] [Related]
15. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis. Le Chevalier T; Pujol JL; Douillard JY; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S; Besson F Semin Oncol; 1994 Oct; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766 [TBL] [Abstract][Full Text] [Related]
16. Second-line chemotherapy with bleomycin, methotrexate, and vinorelbine (BMV) for patients with squamous cell carcinoma of the head, neck and esophagus (SCC-HN&E) pretreated with a cisplatin-containing regimen: a phase II study. Moroni M; Giannetta L; Gelosa G; Secondino S; Chillura G; Colombo E; Siena S J Chemother; 2003 Aug; 15(4):394-9. PubMed ID: 12962369 [TBL] [Abstract][Full Text] [Related]
17. Vinorelbine, bleomycin and methotrexate as a salvage therapy for patients with head and neck squamous carcinoma in relapse after cisplatin/fluorouracil. Iop A; Cartei G; Isaia A Ann Oncol; 1998 Feb; 9(2):225-7. PubMed ID: 9553671 [TBL] [Abstract][Full Text] [Related]
18. Methotrexate, vinblastine, epidoxorubicin, and bleomycin as second-line chemotherapy for recurrent and/or metastatic squamous cell carcinoma of the head and neck. Gebbia V; Valenza R; Testa A; Borsellino N; Cannata G; Restivo S; Speciale R; Ingria F; Spadafora G; Gebbia N ORL J Otorhinolaryngol Relat Spec; 1994; 56(5):279-82. PubMed ID: 7526312 [TBL] [Abstract][Full Text] [Related]
19. [Acute pain due to vinorelbine]. Cabrera Rodríguez J; Muñoz García J Rev Clin Esp; 1998 Aug; 198(8):514-6. PubMed ID: 9774881 [TBL] [Abstract][Full Text] [Related]
20. A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design. Vokes EE; Drinkard LC; Samuels BL; Hoffman PC; Watson S; Bitran JD; Haraf DJ; Ferguson MF; Golomb HM Semin Oncol; 1994 Oct; 21(5 Suppl 10):79-83; discussion 83-4. PubMed ID: 7973772 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]